Yes, I believe they will use profits from Sofdra to progress trials - that was the initial reason to buy SB, to dodge downrampers and avoid furthe dilution. Don't forget management have considerable skin in the game, and who wants to become thin skinned.
BOT - Anything but charting, page-8838
-
- There are more pages in this discussion • 2,301 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.015(4.05%) |
Mkt cap ! $699.7M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.0¢ | 37.0¢ | $1.537M | 4.028M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 91664 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |